1. DeJesus-Hernandez M, Mackenzie IR, Boeve BF, et al. (2011) Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron 72: 245-256.
2. Renton AE, Majounie E, Waite A, et al. (2011) A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron 72: 257-268.
3. Gijselinck I, Van Langenhove T, van der Zee J, et al. (2012) A C9orf72 promoter repeat expansion in a Flanders-Belgian cohort with disorders of the frontotemporal lobar degeneration-amyotrophic lateral sclerosis spectrum: a gene identification study. Lancet Neurol 11: 54-65.
4. Lee YB, Chen HJ, Peres JN, et al. (2013) Hexanucleotide repeats in ALS/FTD form length-dependent RNA foci, sequester RNA binding proteins, and are neurotoxic, Cell Rep 5:1178–1186.
5. Rodriguez CM, Todd PK. (2019) New pathologic mechanisms in nucleotide repeat expansion disorders. Neurobiol Dis 130: 104515
6. Green KM, Linsalata AE, Todd PK (2016) RAN translation-What makes it run? Brain Res 1647: 30-42.
7. Saberi, S. Stauffer JE, Jiang J, et al. (2018) Sense-encoded poly-GR dipeptide repeat proteins correlate to neurodegeneration and uniquely co-localize with TDP-43 in dendrites of repeat-expanded C9orf72 amyotrophic lateral sclerosis. Acta Neuropathol 135: 459–474.
8. Sakae, N. Bieniek KF, Zhang YJ, et al. (2018) Poly-GR dipeptide repeat polymers correlate with neurodegeneration and clinicopathological subtypes in C9ORF72-related brain disease. Acta Neuropathol Commun 6: 63.
9. Mackenzie IR, Frick P, Neumann M (2014) The neuropathology associated with repeat expansions in the C9ORF72 gene. Acta Neuropathol 127: 347-357.
10. Babić Leko M, Župunski V, Kirincich J, et al. (2019) Molecular Mechanisms of Neurodegeneration Related to C9orf72 Hexanucleotide Repeat Expansion. Behav Neurol 2019: 2909168.
11. Lee SR, Han J (2017) Mitochondrial Nucleoid: Shield and Switch of the Mitochondrial Genome. Oxid Med Cell Longev 2017:8060949.
12. Podlesniy P, Figueiro-Silva J, Llado A, et al. (2013) Low cerebrospinal fluid concentration of mitochondrial DNA in preclinical Alzheimer disease. Ann Neurol 74: 655-668.
13. Podlesniy P, Vilas D, Taylor P, et al. (2016) Mitochondrial DNA in CSF distinguishes LRRK2 from idiopathic Parkinson's disease. Neurobiol Dis 94: 10-17.
14. Choi SY, Lopez-Gonzalez R, Krishnan G, et al. (2019) C9ORF72-ALS/FTD-associated poly(GR) binds Atp5a1 and compromises mitochondrial function in vivo. Nat Neurosci 22: 851-862.
15. Lopez-Gonzalez R, Lu Y, Gendron TF, et al. (2016) Poly(GR) in C9ORF72-Related ALS/FTD Compromises Mitochondrial Function and Increases Oxidative Stress and DNA Damage in iPSC-Derived Motor Neurons. Neuron 92: 383-391.
16. Alvarez-Mora MI, Podlesniy P, Gelpi E, et al. (2019) Fragile X-associated tremor/ataxia syndrome: Regional decrease of mitochondrial DNA copy number relates to clinical manifestations. Genes Brain Behav 18: e12565.
17. Cowan K, Anichtchik O, Luo S (2019) Mitochondrial integrity in neurodegeneration. CNS Neurosci Ther 25: 825-836.
18. Wang W, Osenbroch P, Skinnes R, et al. (2010) Mitochondrial DNA integrity is essential for mitochondrial maturation during differentiation of neural stem cells. Stem Cells 28: 2195-2204.
19. Szklarczyk R, Nooteboom M, Osiewacz HD (2014) Control of mitochondrial integrity in ageing and disease. Philos Trans R Soc Lond B Biol Sci 369: 20130439.
20. Wei W, Keogh MJ, Wilson I, et al. (2017) Mitochondrial DNA point mutations and relative copy number in 1363 disease and control human brains. Acta Neuropathol Commun 5: 13.
21. Petersen MH, Budtz-Jørgensen E, Sørensen SA, et al. (2014) Reduction in mitochondrial DNA copy number in peripheral leukocytes after onset of Huntington's disease. Mitochondrion 17: 14-
22. Rice AC, Keeney PM, Algarzae NK, et al. (2014) Mitochondrial DNA copy numbers in pyramidal neurons are decreased and mitochondrial biogenesis transcriptome signaling is disrupted in Alzheimer's disease hippocampi. J Alzheimers Dis 40: 319-330.
23. Khalil B, Liévens JC (2017) Mitochondrial quality control in amyotrophic lateral sclerosis: towards a common pathway? Neural Regen Res 12: 1052-1061.
24. Dafinca R, Scaber J, Ababneh N, et al. (2016) C9orf72 Hexanucleotide Expansions Are Associated with Altered Endoplasmic Reticulum Calcium Homeostasis and Stress Granule Formation in Induced Pluripotent Stem Cell-Derived Neurons from Patients with Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Stem Cells 34: 2063-2078.
25. Paillusson S, Stoica R, Gomez-Suaga P, et al. (2016) There's Something Wrong with my MAM; the ER-Mitochondria Axis and Neurodegenerative Diseases. Trends Neurosci 39: 146-157.
26. Davidson YS, Barker H, Robinson AC, et al. (2014) Brain distribution of dipeptide repeat proteins in frontotemporal lobar degeneration and motor neurone disease associated with expansions in C9ORF72. Acta Neuropathol Commun 2: 70.
27. Mackenzie IR, Arzberger T, Kremmer E, et al. (2013) Dipeptide repeat protein pathology in C9ORF72 mutation cases: clinico-pathological correlations. Acta Neuropathol 126: 859-879.
28. Zu T, Liu Y, Banez-Coronel M, et al. (2013) RAN proteins and RNA foci from antisense transcriptsinC9ORF72ALSandfrontotemporaldementia. Proc Natl Acad Sci 110: E4968–E4977.
29. Lee YB, Baskaran P, Gomez-Deza J, et al. (2017) C9orf72 poly GA RAN-translated protein plays a key role in amyotrophic lateral sclerosis via aggregation and toxicity. Hum Mol Genet 26: 4765-4777.
30. Chew J, Gendron TF, Prudencio M, et al. (2015) Neurodegeneration. C9ORF72 repeat expansions in mice cause TDP-43 pathology, neuronal loss, and behavioral deficits. Science 348: 1151-1154.
31. Gendron TF, Petrucelli L (2018) Disease Mechanisms of C9ORF72 Repeat Expansions. Cold Spring Harb Perspect Med 8: a024224.
32. Cook CN, Wu Y, Odeh HM, et al. (2020) C9orf72 poly(GR) aggregation induces TDP-43 proteinopathy. Sci Transl Med 12: eabb3774.
33. Briston T, Hicks AR (2018) Mitochondrial dysfunction and neurodegenerative proteinopathies: mechanisms and prospects for therapeutic intervention. Biochem Soc Trans 46: 829-842.
34. Mackenzie IR, Frick P, Grässer FA, et al. (2015) Quantitative analysis and clinico-pathological correlations of different dipeptide repeat protein pathologies in C9ORF72 mutation carriers. Acta Neuropathol 130: 845-861.
35. Schludi MH, May S, Grasser FA, et al. (2015) Distribution of dipeptide repeat proteins in cellular models and C9orf72 mutation cases suggests link to transcriptional silencing. Acta Neuropathol 130: 537– 555.